The new “2022 China Ophthalmic Market Report” features updated market forecasts through 2027, expanded analysis of regulations, and new coverage of AI technology in diagnostics. The report now covers more Chinese companies, including providing more competitor profiles, in addition to providing more analysis of ophthalmic product candidates at Chinese pharmaceutical companies and a listing of companies with ophthalmic products in China. The report also examines the slower growth in cataract surgery, as the government shifts its focus from the front of the eye to myopia prevention and chronic eye disease.
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.